NVCR
NovoCure Limited
NASDAQ · JEHealthcareMedical - Instruments & Supplies
$15.94+0.13%
Price as of Jul 20, 2026
NVCR capital
NovoCure Limited capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.71x
- Net debt / equity
- 0.42x
- Debt / assets
- 0.30x
- Debt / EBITDA
- -1.51x
- Net debt / EBITDA
- -0.89x
Liquidity & coverage
- Current ratio
- 2.90x
- Quick ratio
- 2.70x
- Cash ratio
- 2.03x
- Interest coverage
- -76.43x
- EBITDA / interest
- -64.77x
- Working capital
- $414.1M
Cash & dividend
- FCF / debt
- -0.20x
- Cash flow / debt
- -0.11x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.